Skip to content

Instantly share code, notes, and snippets.

@philiptzou
Created February 8, 2022 20:09
Show Gist options
  • Save philiptzou/43ea52b1a855cfc60145c2ba808e5a23 to your computer and use it in GitHub Desktop.
Save philiptzou/43ea52b1a855cfc60145c2ba808e5a23 to your computer and use it in GitHub Desktop.
ref_name subject_name subject_species birth_year immune_status num_subjects note
Bronstein21 Patient 1 Human 1953 1 Immunocompromised
Sabin21 P3 Human 1 Household case report
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d1
Jensen21 Patient 6 Human 1955 1 prolonged infection, d20
Baang21 Patient Human 1 Immunocompromised
Sabin21 P4 Human 1 Household case report
Choudhary21 ACTIV-2/A5401 trial Human 111
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d55
Sabin21 P1 Human 1 Household case report
Copin21 Non-hospitalized high dose patients Human 238 ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person)
Jensen21 Patient 3 Human 1958 1 prolonged infection, d81
Sabin21 P5 Human 1 Household case report
Choi20 MA-JLL Human 1975 1 prolonged infection, T0d25
Choi20 MA-JLL Human 1975 1 prolonged infection, T1d81
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d93
Choi20 MA-JLL Human 1975 1 prolonged infection, T2d130
Jensen21 Patient 1 Human 1948 1 prolonged infection, d12
Copin21 REGN10933 treatment low dose hamsters Hamster 5 RBD/Treatment
Copin21 Non-hospitalized low dose patients Human 247 ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person)
Truffot21 Patient Human 1949 1 Immunocompromised
Jensen21 Patient 4 Human 1952 1 prolonged infection, d19
Sabin21 P2 Human 1 Household case report
Choi20 MA-JLL Human 1975 1 prolonged infection, T2d128
Peiffer-Smadja21 Patient 5 Human 1957 1 BAM treated
Jensen21 Patient 1 Human 1948 1 prolonged infection, d14
Guigon21 Patient Human 1958 1 Immunocompromised
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d100
Focosi21b VA-CF Human 1948 1 Tested positive in Apr 2021
Williamson21 Patient Human 1940 1 Immunocompromised
Weigang21 BW-FR Human 1962 1 Prolonged infection
Copin21 Placebo prevention hamsters Hamster 5 RBD/Prevention
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d95
Sabin21 P6 Human 1 Household case report
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d89
Chen21b Patient_TA Human 1965 1 Immunocompromised
Peiffer-Smadja21 Patient 2 Human 1986 1 BAM treated
Choi20 MA-JLL Human 1975 1 prolonged infection, T3d152
Copin21 Placebo treatment hamsters Hamster 5 RBD/Treatment
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d54
Copin21 REGEN-COV treatment high dose hamsters Hamster 5 RBD/Treatment
Bazykin21 Patient S Human 1 Immunocompromised
Bronstein21 Patient 2 Human 1988 1 Immunocompromised
Jensen21 Patient 5 Human 1952 1 prolonged infection, d51
Copin21 Hospitalized high dose patients Human 93 ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person)
Peiffer-Smadja21 Patient 1 Human 1934 1 BAM treated
Copin21 Non-hospitalized placebo patients Human 243 ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person)
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d82
Copin21 REGN10987 prevention high dose hamsters Hamster 5 RBD/Prevention
Copin21 REGN10933 prevention high dose hamsters Hamster 5 RBD/Prevention
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d50
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d66
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d98
Copin21 Hospitalized placebo patients Human 91 ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person)
Peiffer-Smadja21 Patient 3 Human 1960 1 BAM treated
Copin21 REGEN-COV prevention low dose hamsters Hamster 5 RBD/Prevention
Stanevich21 Patient S Human 1973 1 prolonged infection
Copin21 REGEN-COV treatment low dose hamsters Hamster 5 RBD/Treatment
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d99
Choi20 MA-JLL Human 1975 1 prolonged infection, T0d18
Copin21 Hospitalized low dose patients Human 88 ≥2 samples from ≥1 subject (uncertain how many samples sequenced per person)
Jensen21 Patient 5 Human 1952 1 prolonged infection, d52
Choi20 MA-JLL Human 1975 1 prolonged infection, T3d143
Jensen21 Patient 2 Human 1978 1 prolonged infection, d9
Hensley21 Patient Human 1948 1 Immunocompromised
Jensen21 Patient 5 Human 1952 1 prolonged infection, d49
Copin21 REGN10933 prevention low dose hamsters Hamster 5 RBD/Prevention
Copin21 REGN10933 treatment high dose hamsters Hamster 5 RBD/Treatment
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d41
Copin21 REGN10987 prevention low dose hamsters Hamster 5 RBD/Prevention
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d56
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d45
Choi20 MA-JLL Human 1975 1 prolonged infection, T1d75
Copin21 REGN10987 treatment low dose hamsters Hamster 5 RBD/Treatment
Copin21 REGN10987 treatment high dose hamsters Hamster 5 RBD/Treatment
Jensen21 Patient 1 Human 1948 1 prolonged infection, d16
Peiffer-Smadja21 Patient 6 Human 1955 1 BAM treated
Copin21 REGEN-COV prevention high dose hamsters Hamster 5 RBD/Prevention
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d37
Karim21 Patient Human 1991 1 Immunocompromised
Peiffer-Smadja21 Patient 4 Human 1924 1 BAM treated
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d57
Avanzato20 WA-RML Human 1949 1 prolonged infection
Lohr21 Patient Human 1966 1 Immunocompromised
Khatamzas21 Patient A Human 1947 1 Prolonged infection
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d101
Choi20 MA-JLL Human 1975 1 prolonged infection, T3d146
Kemp21 Septuagenarian male Human 1945 1 prolonged infection, d86
Nussenblatt21 Patient Human 1 B cell depletion
Borges21 Patient Human 1960 1 Immunocompromised
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment